benign prostatic hyperplasia
Conditions
Interventions
test group:2 bag each time, 2 times a day
control group:1 piece each time, 1 time a day
Sponsors
Dongzhimen Hospital Beijing university of Chinese medicine
Eligibility
Sex/Gender
Male
Age
45 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Aged 45-80 years, male; (2) More than 3 months duration; (3) Corresponding to diagnosis standards; (4) Maximum urinary flow rate <15ml/s; (5) Signed the informed consent; (6) Have stop drug treatment is at least 2 weeks before the visit.
Exclusion criteria
Exclusion criteria: (1) Allergies or allergic constitution; (2) Merge heart, cerebrovascular, liver, kidney and hematopoietic system and other serious primary diseases and psychiatric patients; (3) Severe nervous system disease, cervical stenosis, lumbar disc disease, pelvic or abdominal surgery, caused severe diabetic neurogenic bladder; (4) Bladder neck fibrosis, ureteral ridge between hypertrophy, verumontanum hypertrophy, urethral stricture cause dysuria; (5) Combination of urinary tract infection, urinary stones, men with prostate cancer; (6) Benign prostatic obstruction of invasive treatment failure; (7) Taking drugs may affect the function of bladder outlet; (8) Non-drug therapy indications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QOL;IPSS;maximum urinary flow rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| the residual urine;prostate volume; | — |
Countries
China
Contacts
Public ContactQunchao Yan
Guangzhou Hongyun Medical Scientific and Technological Co., Ltd
Outcome results
None listed